Search - tctmd.com

Displaying 501 - 520 of 773

Sort: Relevancy | Date

News Features

A pesar de los Nuevos Hallazgos, la Duración Óptima del Tratamiento Antiplaquetario Doble Sigue en el Aire

Todd Neale

December 10, 2014

Presentation

AHA 2014 Late Breaking Trials: Duration of Dual Anti-platelet Therapy after Stenting

Presenter: Gregg W. Stone

December 01, 2014

News Daily News

一项元分析对在STEMI患者中采取的“一刀切”式的抗凝血剂策略提出了质疑

L.A. McKeown

November 17, 2014

News Daily News

Un Meta Análisis Cuestiona la Estrategia Anticoagulante ‘Talla Única’ en Pacientes STEMI

L.A. McKeown

November 17, 2014

News Conference News AHA 2014

Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel

Yael L. Maxwell

November 17, 2014

News Daily News

Meta-analysis Questions One-Size-Fits-All Anticoagulant Strategy in STEMI Patients

L.A. McKeown

November 17, 2014

News Conference News AHA 2014

Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients

Yael L. Maxwell

November 16, 2014

News Conference News AHA 2014

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Yael L. Maxwell

November 16, 2014

News Conference News AHA 2014

Long-Term Better than Short-Term Prasugrel After PES Stenting

November 15, 2014

News Conference News AHA 2014

ITALIC Shows Noninferiority of 6-Month DAPT in Good Aspirin Responders

Yael L. Maxwell

November 15, 2014

News Conference News AHA 2014

ISAR-SAFE: Another Randomized Trial Finds 6 Months of DAPT as Good as 12 Months

November 15, 2014

News Daily News

研究探索了在氯吡格雷治疗的PCI患者中，糖尿病对血小板反应性的影响

October 10, 2014

News Daily News

Studies Explore Impact of Diabetes on Platelet Reactivity in Clopidogrel-Treated PCI Patients

October 10, 2014

News Daily News

Estudios Exploran el Impacto de la Diabetes sobre la Reactividad Plaquetaria en Pacientes PCI a Tratamiento con Clopodogrel

October 10, 2014

News Daily News

Registro del CORONOR: Warfarin a Largo Plazo + Agente Antiplaquetario Aumenta las Hemorragias en Pacientes con EAC Estable

L.A. McKeown

October 03, 2014

Presentation TCT 2014

Efficacy and safety of switching from clopidogrel to prasugrel in diabetic patients with acute coronary syndromes treated with drug-elunting stents: results of the ESCAPADA study

Presenter: Armando P?rez de Prado

September 16, 2014

Presentation TCT 2014

Two-Year Clinical Results of Patients Randomized to 3- or 12-Month Dual Antiplatelet After Endeavor Zotarolimus Eluting Stent Implantation In OPTIMIZE

Presenter: Fausto Feres

September 16, 2014

Presentation TCT 2014

Antiplatelet Effects of Clopidogrel and Aspirin During 6 Months of Follow-up After Stent Implantation: An ADAPT-DES Substudy

Presenter: Dietmar Trenk

September 16, 2014

Presentation TCT 2014

Short-Duration Versus Guideline-Recommended 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation

Presenter: Giulio Stefanini

September 16, 2014

Presentation TCT 2014

Comparable outcomes on single use of clopidogrel vs_ dual antiplatelet therapy after coronary stenting in patients with acute myocardial infarction

Presenter: Jun-Hyok Oh

September 16, 2014

Advertisement

A pesar de los Nuevos Hallazgos, la Duración Óptima del Tratamiento Antiplaquetario Doble Sigue en el Aire

AHA 2014 Late Breaking Trials: Duration of Dual Anti-platelet Therapy after Stenting

一项元分析对在STEMI患者中采取的“一刀切”式的抗凝血剂策略提出了质疑

Un Meta Análisis Cuestiona la Estrategia Anticoagulante ‘Talla Única’ en Pacientes STEMI

Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel

Meta-analysis Questions One-Size-Fits-All Anticoagulant Strategy in STEMI Patients

Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Long-Term Better than Short-Term Prasugrel After PES Stenting

ITALIC Shows Noninferiority of 6-Month DAPT in Good Aspirin Responders

ISAR-SAFE: Another Randomized Trial Finds 6 Months of DAPT as Good as 12 Months

研究探索了在氯吡格雷治疗的PCI患者中，糖尿病对血小板反应性的影响

Studies Explore Impact of Diabetes on Platelet Reactivity in Clopidogrel-Treated PCI Patients

Estudios Exploran el Impacto de la Diabetes sobre la Reactividad Plaquetaria en Pacientes PCI a Tratamiento con Clopodogrel

Registro del CORONOR: Warfarin a Largo Plazo + Agente Antiplaquetario Aumenta las Hemorragias en Pacientes con EAC Estable

Efficacy and safety of switching from clopidogrel to prasugrel in diabetic patients with acute coronary syndromes treated with drug-elunting stents: results of the ESCAPADA study

Two-Year Clinical Results of Patients Randomized to 3- or 12-Month Dual Antiplatelet After Endeavor Zotarolimus Eluting Stent Implantation In OPTIMIZE

Antiplatelet Effects of Clopidogrel and Aspirin During 6 Months of Follow-up After Stent Implantation: An ADAPT-DES Substudy

Short-Duration Versus Guideline-Recommended 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation

Comparable outcomes on single use of clopidogrel vs_ dual antiplatelet therapy after coronary stenting in patients with acute myocardial infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content